A detailed history of Rock Springs Capital Management LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,580,488 shares of MIRM stock, worth $66 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
1,580,488
Previous 1,772,038 10.81%
Holding current value
$66 Million
Previous $60.6 Million 1.74%
% of portfolio
2.1%
Previous 1.88%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$33.68 - $44.74 $6.45 Million - $8.57 Million
-191,550 Reduced 10.81%
1,580,488 $61.6 Million
Q2 2024

Aug 14, 2024

SELL
$23.57 - $34.85 $1.99 Million - $2.95 Million
-84,526 Reduced 4.55%
1,772,038 $60.6 Million
Q1 2024

May 15, 2024

BUY
$24.92 - $30.02 $127,092 - $153,102
5,100 Added 0.28%
1,856,564 $46.6 Million
Q4 2023

Feb 14, 2024

BUY
$27.14 - $34.93 $834,039 - $1.07 Million
30,731 Added 1.69%
1,851,464 $54.7 Million
Q2 2023

Aug 14, 2023

BUY
$23.51 - $30.09 $587,750 - $752,250
25,000 Added 1.39%
1,820,733 $47.1 Million
Q3 2022

Nov 14, 2022

BUY
$19.98 - $29.44 $1.56 Million - $2.3 Million
78,000 Added 4.54%
1,795,733 $37.7 Million
Q2 2022

Aug 15, 2022

BUY
$18.42 - $27.5 $949,090 - $1.42 Million
51,525 Added 3.09%
1,717,733 $33.4 Million
Q1 2022

May 16, 2022

BUY
$15.5 - $23.93 $1.97 Million - $3.05 Million
127,394 Added 8.28%
1,666,208 $36.7 Million
Q4 2021

Feb 14, 2022

BUY
$13.05 - $19.35 $172,142 - $255,245
13,191 Added 0.86%
1,538,814 $24.5 Million
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $26,505 - $38,342
1,900 Added 0.12%
1,525,623 $30.4 Million
Q2 2021

Aug 16, 2021

BUY
$15.84 - $20.6 $331,420 - $431,013
20,923 Added 1.39%
1,523,723 $26.3 Million
Q1 2021

May 17, 2021

BUY
$16.29 - $21.92 $102,219 - $137,548
6,275 Added 0.42%
1,502,800 $29.8 Million
Q4 2020

Feb 16, 2021

BUY
$15.75 - $25.45 $2.66 Million - $4.3 Million
168,911 Added 12.72%
1,496,525 $26.1 Million
Q3 2020

Nov 16, 2020

BUY
$18.4 - $26.59 $141,753 - $204,849
7,704 Added 0.58%
1,327,614 $25.6 Million
Q2 2020

Aug 14, 2020

BUY
$11.51 - $20.97 $885,234 - $1.61 Million
76,910 Added 6.19%
1,319,910 $25.7 Million
Q1 2020

May 15, 2020

SELL
$9.38 - $23.79 $18,760 - $47,580
-2,000 Reduced 0.16%
1,243,000 $17.4 Million
Q4 2019

Feb 14, 2020

BUY
$6.84 - $25.9 $3.11 Million - $11.8 Million
454,952 Added 57.59%
1,245,000 $30.5 Million
Q3 2019

Nov 14, 2019

BUY
$9.16 - $14.77 $7.24 Million - $11.7 Million
790,048 New
790,048 $7.95 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.53B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.